Jointly developed by investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group and the Bellvitge University Hospital's Neuroradiology Unit, the Diagnosis in Susceptibility ...

co-leader of VHIO's Prostate Cancer Group, and co-corresponding author of this study. "However, several challenges of NGS testing still impede the widespread implementation of precision medicine ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and ...